Literature DB >> 24113463

Infectious crystalline keratopathy caused by Pseudomonas fluorescens.

Valentín Huerva1, M Carmen Sanchez.   

Abstract

OBJECTIVE: To demonstrate a case of infectious crystalline keratopathy (ICK) caused by Pseudomonas fluoresecens (PF).
METHODS: Case report description.
RESULTS: A 15-year-old female contact lens wearer presented complaining of eye pain and redness in the left eye. The patient reported that she had suffered a corneal scratch a few months earlier, which was treated by her family physician, and that she had felt some discomfort since then. The biomicroscopy showed a central corneal abscess with a crystalline appearance, stromal edema, the Tyndall effect, and abundant fibrin in the anterior chamber. A diagnosis of ICK was made. The culture was positive for gram-negative PF. Pseudomonas fluoresecens was sensitive to cephalosporins, quinolones, and tobramycin.
CONCLUSIONS: No cases of ICK caused by PF have been reported previously. Two previous studies reported that the gram-negative Pseudomonas aeruginosa caused ICK. Unlike other ICK cases in which there is minimal stromal inflammation, the patient presented with an intense inflammatory reaction in the anterior chamber.

Entities:  

Mesh:

Year:  2015        PMID: 24113463     DOI: 10.1097/ICL.0b013e3182a2f91d

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  2 in total

1.  Infectious crystalline keratopathy: Management of three cases with different risk factors.

Authors:  José Lorenzo Romero-Trevejo; Ricardo Bosch-Gili; Encarnación Jiménez-Rodríguez; José Luis González de Gor-Crooke
Journal:  Saudi J Ophthalmol       Date:  2019-01-14

2.  Metagenomic Profiling of Ocular Surface Microbiome Changes in Meibomian Gland Dysfunction.

Authors:  Fuxin Zhao; Dake Zhang; Chaoxiang Ge; Lei Zhang; Peter S Reinach; Xiangjun Tian; Chengcheng Tao; Zhelin Zhao; Chenchen Zhao; Wenjie Fu; Changqing Zeng; Wei Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.